Chemo-Free Maintenance Combo Promising in Pancreatic Cancer

(MedPage Today) -- Pairing a PARP inhibitor and immune checkpoint inhibitor together may be a viable non-cytotoxic maintenance therapy option for patients with platinum-sensitive pancreatic ductal adenocarcinoma (PDAC), according to findings of...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news